BioSpace News Archive

Invitae Corporation today announced that members of its management team will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Tuesday, September 14, 2021 , at 12:30pm Eastern Time .

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced the publication of results from a Phase 2 clinical trial evaluating the safety of fostamatinib for the treatment of hospitalized patients with COVID-19

Cyteir Therapeutics, Inc. announced that its President and Chief Executive Officer Markus Renschler, MD will participate in a fireside chat at the 19th Annual Morgan Stanley Global Healthcare Conference, being held virtually on September 10, 2021, at 11:45am ET.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Citi’s 16th Annual BioPharma Virtual Conference – September 8-10, 2021

Xeris Pharmaceuticals, Inc. today announced that the company has completed enrollment and successfully dosed all participants in a Phase 1 study of levothyroxine (XP-8121) to evaluate the pharmacokinetics, safety and tolerability, and potential for weekly dosing of the investigational, novel, subcutaneous (SC) injection for the treatment of hypothyroidism.

Aleafia Health Inc. is pleased to announce the appointment of David Pasieka to its board of directors.

Science 37 ® Appoints Christine Pellizzari as Chief Legal Officer

Novocure (NASDAQ: NVCR) today announced that William (Bill) Burke has been promoted to Chief Human Resources Officer, effective September 1, 2021.

cPharmaceuticals Inc. today announced that John Tucker, president & chief executive officer, is scheduled to present at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually September 13-15, 2021

Caladrius Biosciences, Inc. today announced the appointment of Dr. Kristen K. Buck as the Company’s Chief Medical Officer (“CMO”).